Advisory Services Network’s TG Therapeutics TGTX Stock Holding History

Advisory Services Network’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$681K	Hold	12,397	–	–	0.01%	1226
2026 Q1	$412K	Sell	12,397 -1,501	-11%	-$44.7K	0.01%	1397
2025 Q4	$414K	Sell	13,898 -2,295	-14%	-$75K	0.01%	1310
2025 Q3	$585K	Sell	16,193 -4,012	-20%	-$132K	0.01%	1115
2025 Q2	$717K	Buy	20,205 +8,054	+66%	+$300K	0.01%	987
2025 Q1	$479K	Buy	12,151 +1,792	+17%	+$60.3K	0.01%	1078
2024 Q4	$312K	Buy	10,359 +1,693	+20%	+$48.6K	0.01%	1281
2024 Q3	$154K	Hold	8,666	–	–	﹤0.01%	1431
2024 Q2	$154K	Buy	+8,666	New	+$138K	﹤0.01%	1431
2024 Q1	–	Sell	-1,465	Closed	-$25K	–	3450
2023 Q4	$25K	Buy	+1,465	New	+$17K	﹤0.01%	2402
2023 Q2	–	Sell	-3,449	Closed	-$51.9K	–	3453
2023 Q1	$51.9K	Hold	3,449	–	–	﹤0.01%	1999
2022 Q4	$40.8K	Buy	+3,449	New	+$25K	﹤0.01%	2079
2021 Q3	–	Sell	-450	Closed	-$17K	–	3047
2021 Q2	$17K	Buy	+450	New	+$17.7K	﹤0.01%	2576
2021 Q1	–	Sell	-400	Closed	-$21K	–	2788
2020 Q4	$21K	Hold	400	–	–	﹤0.01%	2137
2020 Q3	$11K	Buy	+400	New	+$9.21K	﹤0.01%	2395

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Advisory Services Network's TGTX Position: Q2 2026 in Review

Advisory Services Network held its TG Therapeutics (TGTX) position steady in Q2 2026 at 12,397 shares worth $681K. The position accounts for 0.01% of the portfolio, ranked #1226.

Advisory Services Network first reported a position in TGTX in Q3 2020 and has held it in 15 quarters since. The position peaked at $717K in Q2 2025. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Advisory Services Network held 12,397 shares of TG Therapeutics worth $681K as of Q2 2026.
Advisory Services Network left its TG Therapeutics share count unchanged in Q2 2026.
TG Therapeutics made up 0.01% of Advisory Services Network's portfolio in Q2 2026, its #1226 holding.
Advisory Services Network first reported a position in TG Therapeutics in Q3 2020 and has held it in 15 quarters since.
Advisory Services Network's TG Therapeutics position peaked at $717K in Q2 2025.
428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.